Table 3. Gene ontology enrichment analysis for those proteins that showed reduced abundance when ERK1/2 activity was blocked.
Gene name | Protein name |
---|---|
Top enriched GO term — immune response GO:0006955 | |
lfn-γ | Interferon-gamma |
II2rα | Interleukin 2 receptor, alpha chain |
II2 | Interleukin 2 |
Ltα | Lymphotoxin alpha |
Nfil3 | Nuclear factor, interleukin 3 regulated |
Serpinb9 | Serine (or cysteine) peptidase inhibitor, clade B, member 9 |
Tnfsf11 | Tumor necrosis factor (ligand) superfamily, member 11 |
Tnfsf8 | Tumor necrosis factor (ligand) superfamily, member 8 |
Tnfrsf18 | Tumor necrosis factor receptor superfamily, member 18 |
Tnfrsf4 | Tumor necrosis factor receptor superfamily, member 4 |
Tnf | Tumor necrosis factor |
Proteins that showed the greatest drop in abundance (P-value < 0.05 and fold change >2 standard deviations from the mean fold change; two-tailed t-test with unequal variance) or a presence/absence expression profile, were subject to enrichment analysis for biological processes. The top enriched process is presented ‘immune response’ GO:0006955, along with a list of those proteins identified within this enrichment group.